More researches should be devoted to controlling inflammation through antagonizing the cGAS-STING pathway, and we expect that more inhibitors of cGAS-STING will enter clinical trials for COPD treatment in the future. This evidence concerns the gene STING1 and chronic obstructive pulmonary disease.